Vinva Investment Management Ltd
Position in NBIX — Neurocrine Biosciences Inc
CIK 1968109
SYDNEY, C3
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$58,333,210
+$48,440,063 QoQ
Shares Held
346,109
+360.9% QoQ
Ownership
0.340%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#51
of 768 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Vinva Investment Management Ltd holds $108,435,653 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (53.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
346,109 | $58,333,210 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
88,369 | $47,880,975 | |
| 3 | COLL |
Collegium Pharmaceutical, Inc
|
24,992 | $904,710 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
27,587 | $699,882 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
7,452 | $616,876 |
All Filings in NBIX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,333,210 | 346,109 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,893,147 | 75,096 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $10,598,530 | 74,727 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $951,214 | 6,776 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $639,133 | 5,085 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $525,239 | 4,749 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,814,221 | 13,291 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,440,578 | 38,540 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,305,284 | 16,745 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $893,583 | 6,479 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $632,579 | 4,801 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $466,987 | 4,151 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $491,680 | 5,214 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,460,503 | 14,429 | Shares | Sole | 2023-05-11 | |
| No filing history on record for this holder in this stock. | ||||||